Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2000-12-4
pubmed:abstractText
Inhaled corticosteroid therapy in severe persistent asthma has been shown to reduce or eliminate oral corticosteroid (OCS) use while retaining effective asthma control.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0091-6749
pubmed:author
pubmed:issnType
Print
pubmed:volume
106
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
852-60
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11080706-Administration, Inhalation, pubmed-meshheading:11080706-Administration, Oral, pubmed-meshheading:11080706-Adolescent, pubmed-meshheading:11080706-Adult, pubmed-meshheading:11080706-Aged, pubmed-meshheading:11080706-Anti-Asthmatic Agents, pubmed-meshheading:11080706-Anti-Inflammatory Agents, pubmed-meshheading:11080706-Asthma, pubmed-meshheading:11080706-Consumer Product Safety, pubmed-meshheading:11080706-Double-Blind Method, pubmed-meshheading:11080706-Female, pubmed-meshheading:11080706-Glucocorticoids, pubmed-meshheading:11080706-Health Status, pubmed-meshheading:11080706-Humans, pubmed-meshheading:11080706-Male, pubmed-meshheading:11080706-Middle Aged, pubmed-meshheading:11080706-Prednisone, pubmed-meshheading:11080706-Pregnadienediols, pubmed-meshheading:11080706-Quality of Life, pubmed-meshheading:11080706-Respiratory Function Tests
pubmed:year
2000
pubmed:articleTitle
Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma.
pubmed:affiliation
Department of Pulmonary Medicine, Thomas Jefferson Hospital, Philadelphia, PA, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study